INRange Systems, Inc. Selected as One of North America`s Finest and Most Promising Tech Venture Companies

* Reuters is not responsible for the content in this press release.

Mon May 18, 2009 5:28pm EDT

Red Herring 100 North American Award Granted to INRange Systems
ALTOONA, Pa.--(Business Wire)--
INRange Systems, Inc. (www.inrangesystems.com), the developer and supplier of
EMMA®, the first and only FDA cleared device for Remote Medication Management,
announced today that it has been named as one of the "2009 Red Herring 100 North
American Award Winners," a prestigious list honoring the year`s most promising
private technology ventures in North America. 

The Red Herring editorial team selects the most innovative companies from a pool
of over 1,200 applicants. Applicants are judged on both quantitative and
qualitative criteria, such as financial performance, technology innovation,
quality of management, execution of strategy, and integration into their
respective industries. INRange joins the ranks of previous Red Herring Award
Winners including Yahoo, Google, Skype, Salesforce.com, and YouTube. 

INRange`s EMMA® (Electronic Medication Management Assistant) system is rapidly
becoming a standard of care for outpatient treatment. For a few dollars per day,
the EMMA® system extends the reach of telemedicine and enhances the benefits of
remote monitoring devices. The EMMA® system consists of a Medication Delivery
Unit (MDU) utilizing wireless, two-way, web-based communications software that
allows a physician, pharmacist or other licensed practitioner to remotely manage
prescriptions stored and released by the patient-operated MDU. 

This year, INRange plans to accelerate the adoption of its EMMA® system with US
Military and Veterans` Administration for the treatment of soldiers suffering
from traumatic brain injuries, the Program for the All-inclusive Care for the
Elderly (PACE) and for the treatment of Mental Health Patients by late summer.
"It is a product whose time has come," says Tony Pratt, Vice President of Sales
& Marketing. "The management of medications in the outpatient setting is a
national priority and EMMA® is consistent with President Obama`s Healthcare
Initiatives. We are very excited about our prospects and expect strong growth in
the 2nd half of 2009 and 2010." 

INRange was one of 200 finalists, selected from the more than 1200 applicants,
invited to present at the Red Herring Conference in San Diego on May 12th and
13th. At the end of the Conference the Top 100 winners were announced. 

"Being recognized by Red Herring as one of their Top 100 North American
Companies for 2009 was quite surprising," said Chris Bossi, President of
INRange. "We are not located in Silicon Valley and we never expected to receive
such a prestigious award. This award is a tribute to the staff at INRange and
the vision of its founder, Dr. Mary Anne Papp." 

About Red Herring

Red Herring is a global media company uniting the world's best high technology
innovators, venture investors, and business decision-makers in a variety of
forums: a leading innovation magazine; an online daily technology news service;
technology newsletters, and major events for technology leaders around the
globe. Red Herring provides an insider's access to the global innovation
ecosystem, featuring unparalleled insights on the emerging technologies driving
the economy. For more information, visit: www.redherring.com. 

About INRange Systems, Inc.

INRange Systems, Inc. is headquartered in Altoona, Pa. It commercialized its
remote medication management technology, called EMMA®, in August of 2008. It is
the first and only device cleared by the FDA for Remote medication management.
For more information visit: www.inrangesystems.com. 





Red Herring:
Yvonne Caprini, 650-428-2900 ext. 410
ycaprini@redherring.com
OR
INRange Systems, Inc.
Christopher E. Bossi, President, 814-940-1870 ext. 302
cbossi@inrangesystems.com
www.inrangesystems.com

Copyright Business Wire 2009

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.